25
Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th , 2006

Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Embed Size (px)

Citation preview

Page 1: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Decision-basedEvidence Making

Mark D. Smith, MD MBA

National Health Policy ConferenceWashington, DC

February 7th, 2006

Page 2: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006
Page 3: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006
Page 4: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006
Page 5: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Translating Research Into Practice ConferenceWashington, DC

July 24th, 2003

Mark Smith, MD, MBAThe California HealthCare Foundation

TRIP Funding Priorities, or:An odd analogy from the provinces

Page 6: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

0

5,000

10,000

15,000

20,000

25,000

30,000

NIH AHRQ

2004 Annual Budget, in Millions

Translating Research Into Practice ConferenceFederal funding of basic and clinical science

swamps HSR

Page 7: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

An odd analogy `

2003 payroll: $50 million 2003 payroll: $150 million

Dollars spent per win, 2000-2003

A’s: $446,000 Yankees: $1,396,000

ratio: 1 / 3.13 Sources: MLB.com and USA Today baseball salary database

Translating Research Into Practice Conference

Page 8: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

The secrets of the As’ success

• Fast

• Cheap

• Fanatically devoted to practical R & D

• Cunning

Translating Research Into Practice Conference

Page 9: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

The A’s v. HSR

• Fast

• Cheap

• Practical R&D

• Cunning

• Sloooowwwwww• Expensive• Uncontaminated

experiments• Field of Dreams

A’s success Incentives to HS Researchers

Translating Research Into Practice Conference

Page 10: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Ford makes … Cars

Page 11: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

The health care system makes …Visits

Page 12: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Tenure

Health Services Research makes …

Page 13: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

What do we need more of ?

• Meaningful definitions when framing research questions

• Quick turnaround• Research questions driven more by operational

stakeholders’ priorities• Expertise in the management sciences as applied

to health care• Permanent research infrastructure

Translating Research Into Practice Conference

Page 14: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

What drives selection of research topics and methods?

• Money

• Researcher interest and skills

• Researcher incentives

• Data availability

• Potential for publication of findings.

Page 15: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Problematic Researcher Attitudes

• Modeled on biochemical research – researchers’ muse

• Observational Arrogance towards delivery system– town/gown ; “LMD”– “only 65% of patients got …”

Page 16: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Typical Research Incentives

• Big

• Long

• Expensive

• Dedicated staff–Neutron bomb – nothing left of

value to the clinical enterprise

Are for projects to be:

Page 17: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

What data on patients are available?

• Age

• Sex

• “Race”

• Income proxies (e.g. zipcode)

• Co-morbid conditions …

• Etc.

Page 18: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

What patient attributes are meaningful?

• Risk aversion

• Where on diffusion curve

• Assertiveness

Page 19: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

What clinician attributes are meaningful?

• Risk aversion

• Where on diffusion curve

• Income elasticity

Page 20: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Research topics: ask the users

• Medical Directors• Chiefs of staff• Department Chairs• Benefits purchasers• State/local legislators and

regulators• Clinicians

Page 21: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

The Role of Health care IT

IT: the new silver bullet?

Page 22: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

The current state ofhealth care IT

Fast, cheap machines

Connected by

Slow, expensive people

Page 23: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

The greatest contribution of modern IT in health care:

The ability to measure and report quality and the outcomes of policy decisions in speedily and economically

Page 24: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

What do we need?

• Relevance

• Speed

• “good enough” precision

• Analytical attributes and skills unfamiliar to many epidemiologists, health services and policy researchers

• Integrated care/research IT platforms

Page 25: Decision-based Evidence Making Mark D. Smith, MD MBA National Health Policy Conference Washington, DC February 7 th, 2006

Decision-basedEvidence Making

Mark D. Smith, MD MBA

National Health Policy ConferenceWashington, DC

February 7th, 2006